WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. said today that it is satisfied that the thresholds necessary to trigger funding of the program to resolve state and federal VIOXX myocardial infarction (MI) and ischemic stroke (IS) claims in the United States will be met. In fact, the Company expressed its confidence that sufficient enrollments will be verified to exceed the participation threshold requirements. More than 97 percent of eligible claimants now have initiated enrollment in the program.
